Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Juan Carlos Lopez Caro"'
Autor:
Paula Paras Bravo, Juan Carlos Lopez Caro, Juan Luis García Rivero, Pablo González Astorqui, Mariano Rodríguez Porres, Juan Carlos Rodríguez, Antonio Galiana, Margarita Hierro, Jesús Sainz, Alex Mira, Manuel Villanueva, Miguel Santibáñez
Publikováno v:
Respiration. 98:447-454
Background: Chronic obstructive pulmonary disease (COPD) affects up to 65 million people worldwide, and COPD exacerbation causes tissue damage and subsequent loss of lung function. It is a multifactorial event in which respiratory infections are invo
Autor:
Juan Carlos Lopez Caro, Gualberto Diaz Saez, Susana Conde Diez, Juan Luis García Rivero, Ana Viejo Casas, Felix Ortiz Portal
Publikováno v:
Respiratory Medicine. 146:96-105
Background Chronic obstructive pulmonary disease (COPD) is a progressive lung disorder in which airflow is obstructed. Viral or bacterial upper respiratory tract infections (URTIs) may lead to exacerbations. Homeopathic medication administration to C
Autor:
Juan Carlos Lopez Caro, Miguel Santibáñez Margüello, Juan Luis García-Rivero, Jesús Sainz Jiménez
Publikováno v:
Archivos de Bronconeumología (English Edition). 55:611-612
Autor:
Miguel Santibáñez Margüello, Jesús Sainz Jiménez, Juan Luis García-Rivero, Juan Carlos Lopez Caro
Publikováno v:
Archivos de Bronconeumología. 55:611-612
Autor:
Alex Mira, Miguel Santibáñez Margüello, Juan Carlos Lopez Caro, Jesús Sainz Jiménez, Juan Carlos Rodríguez Díaz, Antonio José Galiana Cabrera, Juan Luis García Rivero, Manuel Villanueva Montes
Publikováno v:
Respiratory Infections.
Objectives: To Characterize the microbiota in COPD patients during exacerbation and posterior stabilization. Methods: A good quality expectorated sputum during exacerbation and posterior stabilization was obtained from each patient. A region between
Autor:
Elena Bustamante Estebanez, Lucía Lavín Alconero, Beatriz Josa Fernández, Monica Gozalo Marguello, Juan Carlos López Caro, Jonathan Diez Vallejo, Marta Fernandez Sampedro, Pedro Muñoz Cacho, Carlos Richard Espiga, María Mar García Saiz
Publikováno v:
Trials, Vol 22, Iss 1, Pp 1-12 (2021)
Abstract Background There is no strong evidence that any drug is beneficial either for the treatment of SARS-CoV-2 disease or for post-exposure prophylaxis. Therefore, clinical research is crucial to generate results and evaluate strategies against C
Externí odkaz:
https://doaj.org/article/6486479d2d3848e6a70223b270209caa